Review existing Health Technology Processes as per Commonwealth and Medicines Australia Strategic Agreement

The Commonwealth has entered into a new Strategic Agreement with Medicines Australia (the Agreement) acting on behalf of the innovator medicines industry. The Agreement contains a commitment that the Commonwealth support a Health Technology Assessment Policy and Methods Review (the Review). Part of the Review will involve engaging an expert to undertake an analysis of current methods used by the Pharmaceutical Benefits Advisory Committee, contemporary research and relevant methodologies and purchasing practices used by comparable international jurisdictions. The scope of the work sought by the Department may be expanded to also include an examination of the same matters as applicable to the methods used by the Medical Services Advisory Committee (MSAC) to ensure consistency across HTA.

The review will be overseen by the HTA Review Reference Committee (the Reference Committee), which will be independently chaired and will also include the Chair of the PBAC, a Government nominee, a member nominated by Medicines Australia and a patient representative.

The Department is seeking Tenders to undertake an analysis of current methods used by the PBAC, contemporary research and relevant methodologies and purchasing practices used by comparable international jurisdictions. Analysis of current methods used by other Commonwealth HTA Committees such as the MSAC and implications of the Review for linked activities of these Committees may also be required.